EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Peak nasal inspiratory flow assessment of polyp size and response from SYNAPSE

Amber U Luong, Joshua M Levy, Ludger Klimek, Richard J Harvey, Jared Silver, Steven G Smith, Abby Fuller, Robert Chan, Peter W Hellings

Journal of Allergy and Clinical Immunology: Global · 2024-11 · 3 (4) · 100327

DOI: 10.1016/j.jacig.2024.100327 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology: Global, 2024-11. Verfasst von Amber U Luong und 8 weiteren Autor:innen. Beteiligte Einrichtung: McGovern Medical School of the University of Texas Health Science Center, Houston, Tex. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: GSK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In the phase III SYNAPSE study, mepolizumab plus standard of care reduced total endoscopic nasal polyp score (NPS) versus that with placebo in patients with chronic rhinosinusitis with nasal polyps.

Objective

Our aim was to investigate relationships between NPS and (1) peak nasal inspiratory flow (PNIF) and (2) patient-reported outcomes.

Methods

In this post hoc analysis, patients randomized 1:1 received mepolizumab, 100 mg, or placebo subcutaneously every 4 weeks (plus standard of care). Changes from baseline in PNIF (week 52), visual analog scale scores (overall symptoms, nasal obstruction, and loss of smell [weeks 49-52]), and total 22-Item Sino-Nasal Outcome Test score (week 52) were assessed in patients with or without improvements in NPS (improvement of ≥1 point) or without (improvement of

Schlagwörter

Stichwörter der Autor:innen

Chronic rhinosinusitis with nasal polypsmepolizumabnasal polyp scorepatient-reported outcomespeak nasal inspiratory flow

Autor:innen und Institutionen

  • McGovern Medical School of the University of Texas Health Science Center, Houston, Tex.
  • Emory University School of Medicine, Atlanta, Ga.
  • Center for Rhinology and Allergology, Wiesbaden, Germany.
  • Macquarie Medical School, Sydney, Australia.
  • US Medical Affairs - Respiratory, GSK, Durham, NC.
  • Clinical Sciences, Respiratory, GSK, Durham, NC.

Förderung

  • GSK

Zitieren

APA

Luong, A. U., Levy, J. M., Klimek, L., Harvey, R. J., Silver, J., Smith, S. G., Fuller, A., Chan, R., & Hellings, P. W. (2024). Peak nasal inspiratory flow assessment of polyp size and response from SYNAPSE. Journal of Allergy and Clinical Immunology: Global, 3(4), 100327. https://doi.org/10.1016/j.jacig.2024.100327

Vancouver

Luong AU, Levy JM, Klimek L, Harvey RJ, Silver J, Smith SG, et al. Peak nasal inspiratory flow assessment of polyp size and response from SYNAPSE. Journal of Allergy and Clinical Immunology: Global. 2024;3(4):100327. doi:10.1016/j.jacig.2024.100327

BibTeX
@article{Luong2024,
  author = {Luong, Amber U and Levy, Joshua M and Klimek, Ludger and Harvey, Richard J and Silver, Jared and Smith, Steven G and Fuller, Abby and Chan, Robert and Hellings, Peter W},
  title = {Peak nasal inspiratory flow assessment of polyp size and response from SYNAPSE},
  journal = {Journal of Allergy and Clinical Immunology: Global},
  year = {2024},
  volume = {3},
  number = {4},
  pages = {100327},
  doi = {10.1016/j.jacig.2024.100327}
}
Kostenlos starten →